return to press releases

March 12, 2002

AnVil Announces New Name, Expanded Presence at BioIT World in Boston

Pioneer in life sciences informatics to make its mark at gathering of industry leaders

BioIT World, Boston, Booth #818 - March 12, 2002 - As leaders in life sciences information technologies descend on Boston for BioIT World 2002, Burlington, MA-based AnVil (formerly AnVil Informatics), will appear on the scene with a new name and expanded presence.

AnVil is a pioneering life sciences discovery company that turns data into knowledge, helping clients not only make smarter decisions about future revenue-generating products, but also make these decisions early in the discovery process. AnVil offers a wide spectrum of professional services and custom high-dimensional visualization products and services. The company's new name better reflects their broadened expertise and offerings beyond simply informatics.

"Our business model gives clients access to our teams of highly experienced chemists, life scientists, MDs, biostatisticians, mathematicians, data miners, software engineers, and IT specialists," said Dr. Richard D. Gill, President and Chief Executive Officer of AnVil. "In addition to applying our custom high-dimensional analysis and visualization technology to help address our clients' challenges, it is AnVil's domain experts that enable us to offer complete solutions in areas such as in silico drug discovery and drug development."

As part of AnVil's tour de force at BioIT World, President and CEO Dr. Richard Gill, Executive Vice President and COO Dr. Michael McManus, and AnVil Founder and Scientific Advisor Dr. Georges Grinstein, will be speaking and presenting at several panels and seminars at the conference.

Dr. Richard Gill
Dr. Gill has over 20 years of business and R&D experience in the pharmaceutical and life sciences industries. Prior to joining AnVil, Dr. Gill served as President and CEO of ActiveCyte, Inc. He was also President and COO of Genome Therapeutics, a $500 million public company and leader in genomics-based drug discovery.

Dr. Michael McManus
Dr. McManus has over 16 years of scientific software and business experience, including operational management, business development, strategic product planning, research and development, product marketing, and product management expertise. He served as CambridgeSoft Corporation's Vice President of Marketing and Business Development for five years, prior to which he directed their activities in software development, research, and technical support.

Dr. Georges Grinstein
Dr. Grinstein is a Professor of Computer Science at the University of Massachusetts, Lowell and Co-Director of the Institute for Visualization and Perception Research, as well as a Founder and Director, R&D of AnVil. He has over 25 years of experience in academia with extensive private consulting activities. Dr. Grinstein has over 50 research grants, numerous publications in journals and conferences, and has been the organizer or chair of national and international conferences and workshops in Computer Graphics, Visualization, and Data Mining.

AnVil Officers' Panels and Seminars Schedule for BioIT World

About AnVil
AnVil is a pioneering life sciences discovery company that turns data into knowledge. AnVil partners with life sciences, pharmaceutical, biotechnology, and healthcare companies, enabling them to see and interpret multiple data sets in integrated, information-rich views. This approach turns data into decision-quality information, generating informed decisions faster and more accurately. Anvil's combination of scientific perspective, expertise and high-dimensional technology uncovers the limitless possibilities within complex data sets.

AnVil is based in Burlington, Massachusetts. For more information, visit www.anvilinfo.com, or call 1-781-272-1600. E-mail inquiries should be sent to: info@anvilinfo.com. AnVil will be at booth #818 on the BioIT World conference floor at the Boston World Trade Center.

Copyright © 2002 AnVil, Inc. All rights reserved.

back to top